MENU
JUL 25, 2019 9:00 AM PDT

The diagnosis matters: elevating the standard of care for women impacted by vaginitis and vaginosis

Sponsored by: BD
Speaker

Abstract
DATE:  July 25, 2019
TIME:   9:00am PT, 12:00pm ET
 
Vaginitis / vaginosis (V/V) is defined as a spectrum of conditions that cause vaginal and sometimes vulvar symptoms, such as itching, burning, irritation, odor, and vaginal discharge. Vulvovaginal complaints are one of the most common reasons for women to seek medical care, resulting in approximately 10 million visits to healthcare providers annually in the United States. V/V comprises an array of conditions including bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV). Though VVC often presents as an uncomplicated infection with sporadic or infrequent episodes, a subset of women may also experience complicated infections characterized as recurrent infections (four or more episodes in a single year), severe infections, and non-albicans VVC infections. Due to overlap in symptom manifestation, it can be difficult to accurately diagnosis V/V, even by the experienced healthcare provider. In this webinar, traditional and new diagnostics methodologies for vaginitis and their impacts on patient management and treatment will be reviewed. 
 
 
Learning Objectives:
  • Describe the complexities and challenges of diagnosing vaginitis and vaginosis due to symptom overlap, co-infection rates, and current guidelines
  • Understand various diagnostic testing options currently available for vaginitis and vaginosis and the benefits and limitations of each
  • Review the impact molecular diagnostic modalities will have on vaginitis and vaginosis diagnostics into the future
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
JUL 25, 2019 9:00 AM PDT

The diagnosis matters: elevating the standard of care for women impacted by vaginitis and vaginosis

Sponsored by: BD


Show Resources
Loading Comments...
Show Resources